SOD2 and ovarian carcinoma: In epithelial ovarian cancer, SIRT3 prevents mitochondrial superoxide surges to promote cell survival by increasing the activity of the manganese superoxide dismutase (SOD2) in detached cancer cells during the metastatic process (Kim et al., 2020).